Ep.421 ~ Largest Controlled Psychedelic Study in the World ~ Dr. David Rabin

Currently, the psychedelic industry is on the leading edge of helping people with trauma, psychological problems, PTSD, chronic distress, illnesses, empathy and many other issues related to the mind, body, thought process and emotions. People are finding that these substances when used in low doses in a controlled manner prescribed by the right person are having an astounding effect on healing people and these studies are coming from legitimate professionals, doctors and scientists that are also astounded by what they are finding. 

Today on the show, we have the doctor/scientist that is currently working on the largest controlled study for psychedelic substances in the world. His name, Dr. David Rabin. Dr. Rabin is a board-certified psychiatrist, neuroscientist, and inventor, and has been studying the impact of chronic stress in humans for more than 10 years. He has specifically focused his research on the clinical translation of non-invasive therapies that improve mood, focus, sleep, and quality of life in treatment-resistant illnesses. Dr. Rabin has six patent applications pending and many more on the way. Dr. Rabin or Dave received his MD in medicine and a PhD in neuroscience from Albany Medical College and trained in psychiatry at Western Psychiatric Institute & Clinic at the University of Pittsburgh Medical Center.

Throughout the show, we discuss with Dave the benefits that science is finding with these substances and the healing effects they deliver. We chat about the many ways that people are healing themselves where traditional therapy and medicine have failed them, how trauma can actually alter the structure of the person’s DNA and then can be passed down up to four generations. And, we discuss the future of these therapies and medicines and how his business ApolloNeuro is using wearable technologies to help people become the best versions of themselves. On top of that, Dave and ApolloNeuro are offering a 45% discount for their products.